1-10 of 10
Ron Schaafsma
Close
Sort by
Journal Articles

Bortezomib-Based Induction and Maintenance Overcomes the Negative Prognostic Impact of Renal Impairment and del17p in Transplant-Eligible Myeloma Patients: Long Term Results from the Phase III HOVON-65/GMMG-HD4 Study after Median 137 Months Follow up

Christof Scheid, MD, Henk Lokhorst, MD PhD, Igor W Blau, MD PhD, Bronno Van Der Holt, PhD, Uta Bertsch, Sonja Zweegman, MD PhD, Katja Weisel, Edo Vellenga, Marie José Kersten, MD PhD, Sandra Croockewit, Elias K Mai, MD, Reinier Raymakers, MD PhD, Dirk Hose, MD, Anna Jauch, Jens Hillengass, MD, Marian Stevens-Kroef, PhD, Marc S Raab, MD PhD, Kai Neben, Stephan Stilgenbauer, Annemiek Broyl, MD PhD, Hans-Walter Lindemann, MD, Gerard Bos, MD PhD, Peter Brossart, MD, Marinus van Marwijk Kooij, MD PhD, Paula F Ypma, MD PhD, Ulrich Dührsen, Prof, MD PhD, Ron Schaafsma, MD PhD, Thomas Hielscher, Hans Salwender, Hartmut Goldschmidt, MD, Pieter Sonneveld
Journal: Blood
Blood (2019) 134 (Supplement_1): 3308.
https://doi.org/10.1182/blood-2019-129684
Published: 2019
Journal Articles

Efficacy and Safety of First-Line Therapy with Chlorambucil, Rituximab and Individualized Dose Lenalidomide in FCR-Unfit Patients with Advanced Chronic Lymphocytic Leukemia (CLL): A Phase I/II HOVON Trial

Arnon P. Kater, MD, Marinus H.J. H.J. Van Oers, MD PhD, Yvette Norden, Roberto D. Liu, Martin R. Schipperus, Martine Chamuleau, MD PhD, Marcel Nijland, MD, Jeanette K. Doorduijn, MD PhD, Michel van Gelder, MDPhD, Mels Hoogendoorn, MDPhD, Fransien Croon-de Boer, Shulamit Wittebol, Martijn Kerst, MDPhD, Willem Marijt, Ward Posthuma, MD PhD, Reinier Raymakers, MDPhD, Ron Schaafsma, MDPhD, Johan Dobber, Sabina Kersting, MDPhD, Mark-David Levin
Journal: Blood
Blood (2017) 130 (Supplement 1): 4328.
https://doi.org/10.1182/blood.V130.Suppl_1.4328.4328
Published: 2017
Journal Articles

Autologous peripheral blood stem cell transplantation for acute myeloid leukemia

Clinical Trials & Observations
Edo Vellenga, Wim van Putten, Gert J. Ossenkoppele, Leo F. Verdonck, Matthias Theobald, Jan J. Cornelissen, Peter C. Huijgens, Johan Maertens, Alois Gratwohl, Ron Schaafsma, Urs Schanz, Carlos Graux, Harry C. Schouten, Augustin Ferrant, Mario Bargetzi, Martin F. Fey, Bob Löwenberg, for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), and Swiss Group for Clinical Cancer Research Collaborative Group (SAKK)
Journal: Blood
Blood (2011) 118 (23): 6037–6042.
https://doi.org/10.1182/blood-2011-07-370247
Published: 2011
Includes: Supplemental data
Journal Articles

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

Clinical Trials & Observations
Francesca Gay, Alessandra Larocca, Pierre Wijermans, Federica Cavallo, Davide Rossi, Ron Schaafsma, Mariella Genuardi, Alessandra Romano, Anna Marina Liberati, Agostina Siniscalchi, Maria T. Petrucci, Chiara Nozzoli, Francesca Patriarca, Massimo Offidani, Roberto Ria, Paola Omedè, Benedetto Bruno, Roberto Passera, Pellegrino Musto, Mario Boccadoro, Pieter Sonneveld, Antonio Palumbo
Journal: Blood
Blood (2011) 117 (11): 3025–3031.
https://doi.org/10.1182/blood-2010-09-307645
Published: 2011
Journal Articles

Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study

Clinical Trials & Observations
Bob Löwenberg, Joachim Beck, Carlos Graux, Wim van Putten, Harry C. Schouten, Leo F. Verdonck, Augustin Ferrant, Pieter Sonneveld, Mojca Jongen-Lavrencic, Marie von Lilienfeld-Toal, Bart J. Biemond, Edo Vellenga, Dimitri Breems, Hilde de Muijnck, Ron Schaafsma, Gregor Verhoef, Hartmut Döhner, Alois Gratwohl, Thomas Pabst, Gert J. Ossenkoppele, Johan Maertens, for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), German Austrian AML Study Group (AMLSG), Swiss Group for Clinical Cancer Research Collaborative Group (SAKK)
Journal: Blood
Blood (2010) 115 (13): 2586–2591.
https://doi.org/10.1182/blood-2009-10-246470
Published: 2010
Journal Articles

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

Henk M. Lokhorst, Bronno van der Holt, Sonja Zweegman, Edo Vellenga, Sandra Croockewit, Marinus H. van Oers, Peter von dem Borne, Pierre Wijermans, Ron Schaafsma, Okke de Weerdt, Shulamiet Wittebol, Michel Delforge, Henriëtte Berenschot, Gerard M. Bos, Kon-Siong G. Jie, Harm Sinnige, Marinus van Marwijk-Kooy, Peter Joosten, Monique C. Minnema, Rianne van Ammerlaan, Pieter Sonneveld, for Dutch-Belgian Hemato-Oncology Group (HOVON)
Journal: Blood
Blood (2010) 115 (6): 1113–1120.
https://doi.org/10.1182/blood-2009-05-222539
Published: 2010
Journal Articles

Multiple myeloma–reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene

Cornelis A. M. van Bergen, Michel G. D. Kester, Inge Jedema, Mirjam H. M. Heemskerk, Simone A. P. van Luxemburg-Heijs, Freke M. Kloosterboer, W. A. Erik Marijt, Arnoud H. de Ru, M. Ron Schaafsma, Roel Willemze, Peter A. van Veelen, J. H. Frederik Falkenburg
Journal: Blood
Blood (2007) 109 (9): 4089–4096.
https://doi.org/10.1182/blood-2006-08-043935
Published: 2007
Journal Articles

Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer

Elisabeth H. Slager, M. Willy Honders, Edith D. van der Meijden, Simone A. P. van Luxemburg-Heijs, Freke M. Kloosterboer, Michel G. D. Kester, Inge Jedema, W. A. Erik Marijt, M. Ron Schaafsma, Roel Willemze, J. H. Frederik Falkenburg
Journal: Blood
Blood (2006) 107 (12): 4954–4960.
https://doi.org/10.1182/blood-2005-09-3883
Published: 2006
Journal Articles

Intensive Versus Double Intensive Therapy in Untreated Multiple Myeloma: Updated Analysis of the Randomized Phase III Study HOVON 24 MM.

Pieter Sonneveld, Bronno van der Holt, Christine Segeren, Edo Vellenga, Reinier Raymakers, Gregor Verhoef, Ron Schaafsma, Marinus van Oers, Pierre Weijermans, Wim Fibbe, Shulamit Wittebol, Marinus van Marwijk, Douwe Biesma, Joke Baars, Harry Schouten, Petra Westveer, Monique Steijaert, Henk Lokhorst
Journal: Blood
Blood (2004) 104 (11): 948.
https://doi.org/10.1182/blood.V104.11.948.948
Published: 2004
Journal Articles

The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients

Clinical Trials & Observations
Gert J. Ossenkoppele, Wilfried J. Graveland, Pieter Sonneveld, Simon M. G. J. Daenen, Douwe H. Biesma, Leo F. Verdonck, M. Ron Schaafsma, Petra H. M. Westveer, Godefridus J. Peters, Paul Noordhuis, Petra Muus, Dominik Selleslag, Bronnie van der Holt, Michel Delforge, Bob Löwenberg, Gregor E. G. Verhoef, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)
Journal: Blood
Blood (2004) 103 (8): 2908–2913.
https://doi.org/10.1182/blood-2003-07-2195
Published: 2004